Team ErythroSight seeks experts with pharmaceutical experience in therapeutic development and potential licensing deals for collaboration.

JCSMR led researchers discovered platelets have another function that removes old and damaged red blood cells (RBC) from circulation.

A beyond beginner woodworker and an aficionado of Test cricket and footy.

Recognising outstanding contributions to research and service to the academic and wider community, JCSMR postdoctoral researcher Dr Abhimanu Pandey has been awarded the prestigious Royal Society of New South Wales (RSNSW) Bicentennial Early Career Research and Service Citations Award.

Thirteen PhD and 26 Honours students completed their academic research and graduated from JCSMR this December 2023.

The ErythroSight team has developed a novel therapeutic and manufacturing pipeline that harnesses red blood cell extracellular vesicles to treat retinal degenerations such as age-related macular degeneration (AMD), one of the leading causes of incurable blindness in the developed world.